Asthma

Scientists in Japan investigating new treatments for asthma have made a promising discovery, finding that a fermented soybean product can help temper inflammation associated with the condition in animal models.

Most asthma sufferers will know their symptoms are often worse at night. But why is this the case? A fascinating study has put more than a dozen asthma patients through two rigorous experiments and found the body’s circadian clock may be responsible.

A new article is reporting successful results from preclinical tests for a unique asthma vaccine. The results indicate the vaccine generates antibodies against the inflammatory molecules known to cause severe asthma.

An international team of scientists has identified a protein in the lungs that offers a new target for asthma treatments, along with another common condition affected by inflammation in the lungs, in chronic obstructive pulmonary disease (COPD).

People with chronic respiratory disease tend to produce thicker forms of mucus and scientists have now uncovered one of the key reasons why, raising new treatment possibilities for conditions like asthma, cystic fibrosis and COPD.

A newly published longitudinal study out of Canada has found a strong association between frequent use of household cleaning products and an increased risk of children developing asthma in the first three years of life.

Asthma and other allergic reactions are increasingly common today, and while manageable there’s currently no cure. Now, researchers at Yale University have found a new potential pathway for treatment, targeting cellular "gatekeepers" called microRNA.

Much like the gut, skin and mouth, our respiratory system is home to its own unique microbial population. Intriguing new research has now found a link between specific bacterial populations in the upper airways and the severity of asthma symptoms.

Diagnosing asthma in small children is often challenging, as standard measures such as lung function tests can't be used below a certain age. A new blood-analysis device could help, however, delivering definitive results in less than two hours.

Early clinical trial results are suggesting a novel drug designed to inhibit the activity of a key immune signaling molecule could become a promising new treatment for atopic dermatitis, a very common inflammatory skin condition.

A novel study has for the first time detected significant accumulations of fatty tissue in airway walls of obese and overweight people suggesting these accumulations may explain why overweight individuals are at higher risk of respiratory disease.

As part of the Human Cell Atlas initiative researchers have mapped the different types of cells in the lungs, and spotted some crucial new differences between healthy and asthma-affected airways that could inspire some new drug targets.